BofA lowered the firm’s price target on Ibotta (IBTA) to $90 from $110 and keeps a Buy rating on the shares. Q3 results came in above consensus on revenue and EBITDA, but Ibotta guided to Q4 sales and EBITDA that missed consensus and management attributed the weaker Q4 guidance on exhaustion of CPG budgets, as there is a mismatch between demand and supply, the analyst tells investors. The firm lowered its estimates on near-term uncertainty following the report.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter